Bioseeker

BioSeeker Group is an independent, privately owned company based in Sweden since 1999. They focus on business, competitive intelligence in oncology and operate in two business areas: consulting and publishing. BioSeekers Group's mission is to excel our customer's business operations by objective and unbiased research and analysis.

Results 21 - 40 of 74 go to 1st page

first

previous 1 2 3 4 next

last

Title	Date	Price
Analytical Tool - Cancer Therapeutic Antibodies	Jan 2009	£3,750
Lymphoma Drug Pipeline Update 2009	Jan 2009	£1,370
Analytical Tool - Protein Kinase Inhibitors in Oncology	Jan 2009	£2,835
Leukemia Drug Pipeline Update 2009	Jan 2009	£1,370
Apoptosis in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Hematological Cancers Drug Pipeline Update 2009	Jan 2009	£1,825
Brain Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Breast Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Lung Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Antibodies in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Colorectal Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Angiogenesis in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Analytical Tool - Angiogenesis in Oncology	Jan 2009	£2,835
Bladder Cancer Drug Pipeline Update 2009	Jan 2009	£915
Ovarian Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Liver Cancer Drug Pipeline Update 2009	Jan 2009	£915
Currently Druggable in Colorectal Cancer A Drug Target Competitive Analysis	Dec 2008	£1,780
Currently Druggable in Melanoma A Drug Target Competitive Analysis	Oct 2008	£1,780
Currently Druggable in Prostate Cancer A Drug Target Competitive Analysis	Sep 2008	£1,780